Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minoxidil foam gene expression study in men with androgenetic alopecia
2013-004130-15Phase 2Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of minoxidil in androgenetic alopecia (AGA), sponsored by Charité – Universitätsmedizin Berlin. Primary endpoint: Gene expression differences on affected and unaffected alopecia areas. Started Mar 2014; status: completed.
02
Drugs
minoxidil
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on 2013-004130-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004130-15.